drugset / Trial / NCT02070484
Human Amniotic Tissue-derived Allograft, NuCel, in Posteriolateral Lumbar Fusions for Degenerative Disc Disease
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to compare the effect and safety of NuCel to DBX on patients undergoing posteriolateral lumbar spinal fusions for degenerative disc disease.
Timeline
- Start
- 2014-02
- Primary completion
- 2017-03-24
- Completion
- 2017-03-24
Outcome
Outcome not reported
Stopped (Enrollment): “Poor enrollment”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Demineralized Bone Matrix | Other / unclassified | — | — |
| Subject | NuCel | Cell therapy | — | — |